Cover Image
市場調查報告書

分子診斷市場(PCR、新一代定序、微陣列、感染疾病、遺傳病、腫瘤學檢驗、血液捐贈者篩檢):全球產業分析、規模、市場佔有率、成長、趨勢及預測

Molecular Diagnostics Market (Technology - PCR and Real-Time PCR, Hybridization, Microarray, Transcription-mediated Amplification, and Next-Generation Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

出版商 Transparency Market Research 商品編碼 294642
出版日期 內容資訊 英文 164 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
分子診斷市場(PCR、新一代定序、微陣列、感染疾病、遺傳病、腫瘤學檢驗、血液捐贈者篩檢):全球產業分析、規模、市場佔有率、成長、趨勢及預測 Molecular Diagnostics Market (Technology - PCR and Real-Time PCR, Hybridization, Microarray, Transcription-mediated Amplification, and Next-Generation Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
出版日期: 2017年01月25日 內容資訊: 英文 164 Pages
簡介

分子診斷雖然至今都需要高技術專家與高價實驗,但成本削減及客製化的改良、先進技術的引進下,而廣泛利用於分子診斷檢查上。由於院內感染發病率的上升、高齡化、患者意識的提升等要素,一般預測該市場在今後將會持續普及。

本報告提供全球分子診斷市場相關調查,彙整各種技術和應用趨勢,市場規模與未來預測,各地區趨勢,競爭環境等資料,連同企業簡介,為您概述為以下內容。

第1章 序論

第2章 摘要整理

第3章 市場趨勢

  • 概要
  • 推動市場的要素
    • 癌症發病數量的增加
    • 高齡化
    • 慢性疾病發病率的上升
    • 搭配診斷及個人化醫療的認識和普及度擴大
  • 阻礙要素
    • 給付政策相關問題
  • 市場機會
    • 技術進步
    • 新興市場開拓
  • 波特五力分析模式
  • 市場魅力度分析:各地區

第4章 分子診斷市場:各技術

  • 概要
  • 聚合酵素鏈鎖反應(PCR)
  • 轉錄擴增(TMA)
  • 微陣列
  • 混合化(ISH及FISH)
  • 新一代定序
  • 其他

第5章 分子診斷市場:各技術:各方面應用

  • 概要
  • 感染疾病
  • 基因學
  • 血液捐贈者篩檢
  • 其他

第6章 分子診斷市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他各國

第7章 分子診斷市場佔有率分析

  • 全球分子診斷市場各主要企業市場佔有率分析

第8章 建議

  • 成功策略
    • 跟醫療保健服務供應商的長期契約
    • 中國,印度,俄羅斯等新興國家的投資
    • 流通網的擴大

第9章 企業簡介

  • Abbott Laboratories
  • Becton Dickinson & Company
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Danaher Corporation (Beckman Coulter)
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc. (Gen-Probe)
  • Myriad Genetics, Inc.
  • Novartis International AG
  • Qiagen
  • Quest Diagnostics, Inc.
  • Siemens AG
  • Thermo Fisher Scientific

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Title: Molecular Diagnostics Market (Technology - PCR and Real-Time PCR, Hybridization, Microarray, Transcription-mediated Amplification, and Next-Generation Sequencing; Application - Infectious Diseases, Oncology, Blood Screening, Microbiology, Genetic Testing, and Women's Health; End User: Hospitals, Diagnostic Laboratories, Blood Banks, Academics, and Research) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025.

Global Molecular Diagnostics Market: Overview

This report on the molecular diagnostics market studies the current and future prospects of the market globally. Growing incidences of chronic infectious diseases such as tuberculosis, HIV/AIDS, diarrhea, pneumonia hepatitis, in addition to increasing geriatric population, and rising number of biotechnology companies is expected to accentuate the growth of global molecular diagnostics market. The global molecular diagnostics market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global molecular diagnostics market with respect to market segments based on technology, application, end user and their geographic analysis.

Global Molecular Diagnostics Market: Segmentation

Based on technology, the molecular diagnostics market has been segmented into six major categories: PCR and real-time PCR, hybridization, microarray, transcription-mediated amplification, next-generation sequencing and others which includes mass spectrometry etc. These are the major techniques which are used in molecular diagnostics for diagnosis of disease. Likewise, on the basis of application, the global molecular diagnostics market has been segmented into infectious diseases, oncology, blood screening, microbiology, genetic testing and women's health. Infectious disease testing has been segmented into two major categories, namely, virology and bacteriology. The market segments have been extensively analyzed based on usefulness, adoption, efficacy, revenue, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2015 to 2025. The molecular diagnostics market report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2015 as the base year. A brief patient pool analysis by infectious disease, cancer and cardiovascular disease have also been discussed in the global molecular diagnostics report.

Based on End User the global molecular diagnostics market is segmented as hospitals, diagnostic laboratories, blood banks, academics & research and others. The market size and forecast for each of these end user has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2015 as the base year.

Global Molecular Diagnostics Market: Regional Outlook

Geographically, the molecular diagnostics market in Europe has been categorized into five major regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2015 as the base year. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving that is supply side driver, demand side driver and economic driver, restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter's Five Forces analysis, and market share analysis by key players, competitive matrix thus presenting a thorough analysis of the overall competitive scenario in the global molecular diagnostics market.

Key Players Mentioned in this Report are:

Current and future trends has also been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the global molecular diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments, SWOT analysis. Major players profiled in this report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, QIAGEN N.V. ,bioMérieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Siemens AG and Thermo Fisher Scientific Inc., and others.

The global molecular diagnostics market is segmented as given below:

Global Molecular Diagnostics Market, by Technology

  • PCR and Real-Time PCR
  • Hybridization
  • Microarray
  • Transcription-Mediated Amplification
  • Next-Generation Sequencing
  • Others (Mass Spectrometry, etc.)

Global Molecular Diagnostics Market, by Application

  • Infectious Diseases
  • Oncology
  • Blood Screening
  • Microbiology
  • Genetic Testing
  • Women's Health

Global Molecular Diagnostics Market, by End Use

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Academics
  • Research

Global Molecular Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market definition and scope
  • 1.2. Market segmentation
  • 1.3. Key research objectives
  • 1.4. Research highlights

2. Assumptions and research methodology

3. Executive summary: global molecular diagnostics market

4. Market overview

  • 4.1. Introduction
    • 4.1.1. Product definition
  • 4.2. Market dynamics
    • 4.2.1. Drivers
      • 4.2.1.1. Economic drivers
      • 4.2.1.2. Supply side drivers
      • 4.2.1.3. Demand side drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities

5. Global Molecular Diagnostics Market Analysis and Forecast, 2017-2025

  • 5.1. Market Revenue Projections (US$ Mn)
  • 5.2. Porter's Five forces Analysis: Global Molecular Diagnostics Market
  • 5.3. Future Market Outlook

6. Global Molecular Diagnostics Market Analysis and Forecast, By Technology

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Key Trends
  • 6.4. Market Value (US$ Mn) Forecast By Technology
    • 6.4.1. PCR and Real-Time PCR
    • 6.4.2. Hybridization
    • 6.4.3. Microarray
    • 6.4.4. Transcription-Mediated Amplification
    • 6.4.5. Next-Generation Sequencing
    • 6.4.6. Others (Mass Spectrometry etc.)
  • 6.5. Market Attractiveness By Technology

7. Global Molecular Diagnostics Market Analysis and Forecast, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Key Trends
  • 7.4. Market Value (US$ Mn) Forecast By Application
    • 7.4.1. Infectious Diseases
      • 7.4.1.1. Virology
      • 7.4.1.2. Bacteriology
    • 7.4.2. Oncology
    • 7.4.3. Blood Screening
    • 7.4.4. Microbiology
    • 7.4.5. Genetic Testing
    • 7.4.6. Women's Health
  • 7.5. Market Attractiveness By Application

8. Global Molecular Diagnostics Market Analysis and Forecasts, By End User

  • 8.1. Key Findings
  • 8.2. Policies and Regulations
  • 8.3. Market Value (US$ Mn) Forecast By End User
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostics Laboratories
    • 8.3.3. Blood Banks
    • 8.3.4. Academics & Research
    • 8.3.5. Others
  • 8.4. Market Attractiveness By End User

9. Global Molecular Diagnostics Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Policies and Regulations
  • 9.3. Market Value (US$ Mn) Forecast By Region
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East and Africa
  • 9.4. Market Attractiveness By Region

10. North America Molecular Diagnostics Market Analysis and Forecast

  • 10.1. Key Findings
  • 10.2. Policies and Regulations
  • 10.3. Key Trends
  • 10.4. Market Value (US$ Mn) Forecast By Technology
    • 10.4.1. PCR and Real-Time PCR
    • 10.4.2. Hybridization
    • 10.4.3. Microarray
    • 10.4.4. Transcription-Mediated Amplification
    • 10.4.5. Next-Generation Sequencing
    • 10.4.6. Others (Mass Spectrometry etc.)
  • 10.5. Market Value (US$ Mn) and Forecast By Application
    • 10.5.1. Infectious Diseases
      • 10.5.1.1. Virology
      • 10.5.1.2. Bacteriology
    • 10.5.2. Oncology
    • 10.5.3. Blood Screening
    • 10.5.4. Microbiology
    • 10.5.5. Genetic Testing
    • 10.5.6. Women's Health
  • 10.6. Market Value (US$ Mn) Forecast By End User
    • 10.6.1. Hospitals
    • 10.6.2. Diagnostics Laboratories
    • 10.6.3. Blood Banks
    • 10.6.4. Academics & Research
    • 10.6.5. Others
  • 10.7. Market Value (US$ Mn) Forecast By Country
    • 10.7.1. U.S.
    • 10.7.2. Canada
  • 10.8. Market Attractiveness Analysis
    • 10.8.1. By Technology
    • 10.8.2. By Application
    • 10.8.3. By End User
    • 10.8.4. By Country

11. Europe Molecular Diagnostics Market Analysis and Forecast

  • 11.1. Key Findings
  • 11.2. Policies and Regulations
  • 11.3. Key Trends
  • 11.4. Market Value (US$ Mn) Forecast By Technology
    • 11.4.1. PCR and Real-Time PCR
    • 11.4.2. Hybridization
    • 11.4.3. Microarray
    • 11.4.4. Transcription-Mediated Amplification
    • 11.4.5. Next-Generation Sequencing
    • 11.4.6. Others (Mass Spectrometry etc.)
  • 11.5. Market Value (US$ Mn) Forecast By Application
    • 11.5.1. Infectious Diseases
      • 11.5.1.1. Virology
      • 11.5.1.2. Bacteriology
    • 11.5.2. Oncology
    • 11.5.3. Blood Screening
    • 11.5.4. Microbiology
    • 11.5.5. Genetic Testing
    • 11.5.6. Women's Health
  • 11.6. Market Value (US$ Mn) Forecast By End User
    • 11.6.1. Hospitals
    • 11.6.2. Diagnostics Laboratories
    • 11.6.3. Blood Banks
    • 11.6.4. Academics & Research
    • 11.6.5. Others
  • 11.7. Market Value (US$ Mn) Forecast By Country
    • 11.7.1. Germany
    • 11.7.2. France
    • 11.7.3. U.K.
    • 11.7.4. Italy
    • 11.7.5. Spain
    • 11.7.6. Rest of Europe
  • 11.8. Market Attractiveness Analysis
    • 11.8.1. By Technology
    • 11.8.2. By Application
    • 11.8.3. By End User
    • 11.8.4. By Country

12. Asia Pacific Molecular Diagnostics Market Analysis and Forecast

  • 12.1. Key Findings
  • 12.2. Policies and Regulations
  • 12.3. Key Trends
  • 12.4. Market Value (US$ Mn) Forecast By Technology
    • 12.4.1. PCR and Real-Time PCR
    • 12.4.2. Hybridization
    • 12.4.3. Microarray
    • 12.4.4. Transcription-Mediated Amplification
    • 12.4.5. Next-Generation Sequencing
    • 12.4.6. Others (Mass Spectrometry etc.)
  • 12.5. Market Value (US$ Mn) Forecast By Application
    • 12.5.1. Infectious Diseases
      • 12.5.1.1. Virology
      • 12.5.1.2. Bacteriology
    • 12.5.2. Oncology
    • 12.5.3. Blood Screening
    • 12.5.4. Microbiology
    • 12.5.5. Genetic Testing
    • 12.5.6. Women's Health
  • 12.6. Market Value (US$ Mn) Forecast By End User
    • 12.6.1. Hospitals
    • 12.6.2. Diagnostics Laboratories
    • 12.6.3. Blood Banks
    • 12.6.4. Academics & Research
    • 12.6.5. Others
  • 12.7. Market Value (US$ Mn) Forecast By Country
    • 12.7.1. China
    • 12.7.2. Japan
    • 12.7.3. Australia
    • 12.7.4. India
    • 12.7.5. Rest of Asia Pacific
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Technology
    • 12.8.2. By Application
    • 12.8.3. By End User
    • 12.8.4. By Country

13. Latin America Molecular Diagnostics Market Analysis and Forecast

  • 13.1. Key Findings
  • 13.2. Policies and Regulations
  • 13.3. Key Trends
  • 13.4. Market Value (US$ Mn) Forecast By Technology
    • 13.4.1. PCR and Real-Time PCR
    • 13.4.2. Hybridization
    • 13.4.3. Microarray
    • 13.4.4. Transcription-Mediated Amplification
    • 13.4.5. Next-Generation Sequencing
    • 13.4.6. Others (Mass Spectrometry etc.)
  • 13.5. Market Value (US$ Mn) Forecast By Application
    • 13.5.1. Infectious Diseases
      • 13.5.1.1. Virology
      • 13.5.1.2. Bacteriology
    • 13.5.2. Oncology
    • 13.5.3. Blood Screening
    • 13.5.4. Microbiology
    • 13.5.5. Genetic Testing
    • 13.5.6. Women's Health
  • 13.6. Market Value (US$ Mn) Forecast By End User
    • 13.6.1. Hospitals
    • 13.6.2. Diagnostics Laboratories
    • 13.6.3. Blood Banks
    • 13.6.4. Academics & Research
    • 13.6.5. Others
  • 13.7. Market Value (US$ Mn) Forecast By Country
    • 13.7.1. Brazil
    • 13.7.2. Mexico
    • 13.7.3. Rest of Latin America
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Technology
    • 13.8.2. By Application
    • 13.8.3. By End User
    • 13.8.4. By Country

14. Middle East and Africa Molecular Diagnostics Market Analysis and Forecast

  • 14.1. Key Findings
  • 14.2. Policies and Regulations
  • 14.3. Key Trends
  • 14.4. Market Value (US$ Mn) Forecast By Technology
    • 14.4.1. PCR and Real-Time PCR
    • 14.4.2. Hybridization
    • 14.4.3. Microarray
    • 14.4.4. Transcription-Mediated Amplification
    • 14.4.5. Next-Generation Sequencing
    • 14.4.6. Others (Mass Spectrometry etc.)
  • 14.5. Market Value (US$ Mn) Forecast By Application
    • 14.5.1. Infectious Diseases
      • 14.5.1.1. Virology
      • 14.5.1.2. Bacteriology
    • 14.5.2. Oncology
    • 14.5.3. Blood Screening
    • 14.5.4. Microbiology
    • 14.5.5. Genetic Testing
    • 14.5.6. Women's Health
  • 14.6. Market Value (US$ Mn) Forecast By End User
    • 14.6.1. Hospitals
    • 14.6.2. Diagnostics Laboratories
    • 14.6.3. Blood Banks
    • 14.6.4. Academics & Research
    • 14.6.5. Others
  • 14.7. Market Value (US$ Mn) Forecast By Country
    • 14.7.1. Saudi Arabia
    • 14.7.2. South Africa
    • 14.7.3. Rest of MEA
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Technology
    • 14.8.2. By Application
    • 14.8.3. By End User
    • 14.8.4. By Country

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2015)
  • 15.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 15.3.1. Abbott Laboratories
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Business Overview
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Becton, Dickinson and Company
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Business Overview
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Bio-Rad Laboratories, Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Business Overview
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. BioMérieux SA
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Business Overview
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Danaher Corporation
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Business Overview
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. F. Hoffmann-La Roche Ltd.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Business Overview
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. QIAGEN N.V.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Business Overview
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Siemens AG
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Business Overview
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Thermo Fisher Scientific Inc.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Business Overview
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview

List of Figures

  • Figure 1: Global Molecular Diagnostic Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 2: Global Molecular Diagnostics Market Value Share, by Technology (2017)
  • Figure 3: Global Molecular Diagnostics Market Value Share, by Application (2017)
  • Figure 4: Global Molecular Diagnostics Market Value Share, by Region (2017)
  • Figure 5: Global Molecular Diagnostics Market Value Share, by End-user (2017)
  • Figure 6: Global Molecular Diagnostic Market Value Share Analysis, by Technology, 2017 and 2025
  • Figure 7: Global Molecular Diagnostic Market Attractiveness Analysis, by Technology, 2016
  • Figure 8: Global PCR and Real-Time PCR Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 9: Global Hybridization Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 10: Global Microarray Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 11: Global Transcription-Mediated Amplification Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 12: Global Next-Generation Sequencing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 13: Global Others (Mass Spectrometry etc.) Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 14: Global Molecular Diagnostics Market Value Share Analysis, by Application, 2017 and 2025
  • Figure 15: Global Molecular Diagnostics Market Attractiveness Analysis, by Application, 2016
  • Figure 16: Global Infectious Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 17: Global Oncology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 18: Global Blood Screening Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 19: Global Microbiology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 20: Global Genetic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 21: Global Women's Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 22: Global Molecular Diagnostic Market Value Share Analysis, by End-user, 2017 and 2025
  • Figure 23: Global Molecular Diagnostic Market Attractiveness Analysis, by End-user, 2016
  • Figure 24: Global Hospital Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 25: Global Diagnostic Laboratories Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 26: Global Blood Banks Centers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 27: Global Academics & Research Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 28: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 29: Global Molecular Diagnostics Market Value Share Analysis, by Region, 2017 and 2025
  • Figure 30: Global Molecular Diagnostics Market Attractiveness Analysis, by Region, 2016
  • Figure 31: North America Molecular Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 32: North America Molecular Diagnostics Market Attractiveness Analysis, by Country, 2016
  • Figure 33: North America Market Value Share Analysis, by Technology Type, 2017 and 2025
  • Figure 34: North America Market Value Share Analysis, by Application, 2017 and 2025
  • Figure 35: North America Market Value Share Analysis, by End-user, 2017 and 2025
  • Figure 36: North America Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 37: North America Market Attractiveness Analysis, by Technology
  • Figure 38: North America Market Attractiveness Analysis, by Application
  • Figure 39: North America Market Attractiveness Analysis, by End-user
  • Figure 40: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 41: Europe Molecular Diagnostics Market Attractiveness Analysis, by Country, 2016
  • Figure 42: Europe Molecular Diagnostics Market Value Share Analysis, by Technology, 2017 and 2025
  • Figure 43: Europe Molecular Diagnostics Market Value Share Analysis, by Application, 2017 and 2025
  • Figure 44: Europe Molecular Diagnostics Market Value Share Analysis, by End-user, 2017 and 2025
  • Figure 45: Europe Molecular Diagnostics Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 46: Europe Molecular Diagnostics Market Attractiveness Analysis, by Technology
  • Figure 47: Europe Molecular Diagnostics Market Attractiveness Analysis, by Application
  • Figure 48: Europe Molecular Diagnostics Market Attractiveness Analysis, by End-user
  • Figure 49: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 50: Asia Pacific Molecular Diagnostics Market Attractiveness Analysis, by Country, 2016
  • Figure 51: Asia Pacific Market Value Share Analysis, by Technology Type, 2017 and 2025
  • Figure 52: Asia Pacific Market Value Share Analysis, by Application, 2017 and 2025
  • Figure 53: Asia Pacific Market Value Share Analysis, by End-user, 2017 and 2025
  • Figure 54: Asia Pacific Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 55: Asia Pacific Market Attractiveness Analysis, by Technology
  • Figure 56: Asia Pacific Market Attractiveness Analysis, by Application
  • Figure 57: Asia Pacific Market Attractiveness Analysis, by End-user
  • Figure 58: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 59: Latin America Molecular Diagnostics Market Attractiveness Analysis, by Country, 2016
  • Figure 60: Latin America Market Value Share Analysis, by Technology Type, 2017 and 2025
  • Figure 61: Latin America Market Value Share Analysis, by Application, 2017 and 2025
  • Figure 62: Latin America Market Value Share Analysis, by End-user, 2017 and 2025
  • Figure 63: Latin America Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 64: Latin America Market Attractiveness Analysis, by Technology
  • Figure 65: Latin America Market Attractiveness Analysis, by Application
  • Figure 66: Latin America Market Attractiveness Analysis, by End-user
  • Figure 67: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 68: Middle East & Africa Molecular Diagnostics Market Attractiveness Analysis By Country, 2016
  • Figure 69: Middle East & Africa Market Value Share Analysis, by Technology Type, 2017 and 2025
  • Figure 70: Middle East & Africa Market Value Share Analysis, by Application, 2017 and 2025
  • Figure 71: Middle East & Africa Market Value Share Analysis, by End User, 2017 and 2025
  • Figure 72: Middle East & Africa Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 73: Middle East & Africa Market Attractiveness Analysis, by Technology
  • Figure 74: Middle East & Africa Market Attractiveness Analysis, by Application
  • Figure 75: Middle East & Africa Market Attractiveness Analysis, by End User
  • Figure 76: Global Molecular Diagnostics Market Share Analysis, by Company

List of Tables

  • Table 1: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015-2025
  • Table 2: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 3: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015-2025
  • Table 4: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 5: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Region, 2015-2025
  • Table 06: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2015-2025
  • Table 07: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 08: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015-2025
  • Table 09: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 10: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 11: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015-2025
  • Table 12: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 13: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015-2025
  • Table 14: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 15: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 16: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2015-2025
  • Table 17: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 18: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015-2025
  • Table 19: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 20: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 21: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2015-2025
  • Table 22: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 23: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015-2025
  • Table 24: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 25: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 26: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015-2025
  • Table 27: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, By Application, 2015-2025
  • Table 28: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, By Infectious Diseases, 2015-2025
  • Table 29: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015-2025
  • Table 30: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015-2025
Back to Top